Diabetes Board decisions

The Board granted an effective date of March 8, 2024 for the grant of service connection for type 2 diabetes mellitus but denied earlier effective dates for atrial fibrillation and congestive heart failure. The other claims were remanded.

The Board granted a 30 percent rating for pancreatic exocrine insufficiency and denied an earlier effective date and a higher rating for diabetes mellitus type II.

The Board denied service connection for all the claimed conditions as there was no evidence of a current disability or that any of the disabilities were related to active duty.

The Veteran's date of entitlement to TDIU most likely arose in 2009, but the earliest effective date granted is November 24, 2014.

The Board denied service connection for deep vein thrombosis, hyperlipidemia, vitamin D deficiency, pre-diabetes, and obstructive sleep apnea. The Veteran's hypertension was not found to be compensable, and the ratings for his depressive disorder and tinnitus were also denied.

The Board denied the Veteran's claim for an initial compensable disability rating for diabetic retinopathy as there were no incapacitating episodes or visual impairment.

The Board granted service connection for type 2 diabetes mellitus and hypertension, both presumed to be related to the Veteran's in-service exposure to herbicide agents.

The Board denied the veteran's claims for an earlier effective date for his diabetes mellitus, a higher rating for PTSD with alcohol use disorder, and a total disability rating due to service-connected disabilities.

The Board granted service connection for right ear hearing loss, tinnitus, diabetes mellitus type II, and Parkinson's disease.

The Board granted service connection for diabetes mellitus type II, hypertension, hypothyroidism, prostate cancer, sleep apnea secondary to service-connected diabetes mellitus, tinea pedis, and lumbar spondylosis.

The Board remands the claims for service connection for an endocrine disorder, to include diabetes, and obstructive sleep apnea (OSA) due to a need for additional evidence regarding potential exposures during service.

The Board denied service connection for multiple conditions, including fatigue, bilateral eye disability, hypertension, diabetes mellitus, GERD, penile condition, left foot disability, and others. Some claims were remanded for further development.

The Board granted service connection for diabetes mellitus but denied it for bilateral hearing loss.

The Board remands the claims for service connection for diabetes mellitus, hypertension, adenocarcinoma of the prostate, and erectile dysfunction due to inadequate toxic exposure risk activities (TERA) memoranda and a need for additional medical opinions.

The Board denied service connection for diabetes mellitus, valvular heart disease (chest pain and cardiac valve stenosis), aortic aneurysm, and hypertension as these conditions were not found to be etiologically related to the Veteran's active duty service.

The Board remands the claim for an addendum VA medical opinion to determine if the Veteran's service-connected PTSD and/or musculoskeletal disabilities caused him to become overweight, which in turn led to his diabetes.

The Veteran was granted special monthly compensation (SMC) based on the need for aid and attendance from July 28, 2023, through September 21, 2024.

The Board granted service connection for diabetic retinopathy, chronic kidney disease, a heart disability, erectile dysfunction, hypertension, a colon disability, major depressive disorder, and diabetes mellitus, type 2. The claims for PTSD, chronic kidney disease, diabetes mellitus, type 2, and hypertension were denied.

The Board remands the issues for further development and readjudication by the AOJ.

The Board granted service connection for bilateral hearing loss and an effective date of October 24, 2022, for obstructive sleep apnea. Other claims were denied or remanded.